- 39.5k views
World’s First Renal Denervation Therapy in an Ectopic kidney
Apollo Hospitals Chennai made history by successfully performing the world’s first Simplicity Spyral renal denervation (RDN) therapy on a 58-year-old man with resistant hypertension and an ectopic kidney. Led by Dr. Refai Showkathali, the procedure involved radiofrequency ablation of two renal arteries, resulting in a significant reduction in the patient's blood pressure from 160/100 mmHg to 130/80 mmHg within a day. This innovative treatment marked the first global use of the FDA-approved Simplicity Spyral RDN catheter in ectopic kidneys, showcasing Apollo Hospitals' leadership in interventional cardiology.
About the Speaker
Dr. Refai Showkathali
Senior Interventional Cardiologist, Apollo Main Hospital, Chennai
Dr. Refai Showkathali is a highly experienced cardiologist with over 22 years of practice, currently affiliated with Apollo Hospitals Greams Road, Chennai. He specializes in advanced interventional cardiology, including complex procedures like CHIP PCI, laser and rotational atherectomy, and zero-contrast PCI for high-risk kidney patients. He is also an expert in structural heart interventions, such as TAVI, TMVR, and pacemaker implantation. Dr. Refai spent 14 years working in renowned UK hospitals before returning to India in 2014. He holds numerous qualifications, including MBBS, FRCP, FACC, and FESC.
Upcoming Case Discussions
Acne: Disorders and Treatment Approaches
Acne is a common dermatological condition caused by clogged pores, excess sebum production, bacterial growth, and inflammation. It can manifest as blackheads, whiteheads, papules, pustules, or cysts, often leading to scarring if untreated. Various factors, including hormonal changes, diet, stress, and genetics, influence its severity. Treatment approaches range from topical and oral medications, such as retinoids, antibiotics, and hormonal therapy, to advanced procedures like chemical peels and laser therapy. A personalized skincare regimen, along with lifestyle modifications, plays a crucial role in managing and preventing acne.
Congenital Uterine Anomalies
Congenital uterine anomalies are structural abnormalities of the uterus resulting from improper fusion, canalization, or resorption of the Müllerian ducts during fetal development. These anomalies include septate, bicornuate, unicornuate, and didelphys uterus, among others. They can be asymptomatic or associated with infertility, recurrent pregnancy loss, preterm birth, or abnormal menstruation. Diagnosis is typically made using imaging modalities like ultrasound, MRI, or hysterosalpingography. Treatment depends on the type and severity of the anomaly, with surgical correction such as hysteroscopic septum resection often indicated in symptomatic cases. Early detection is crucial for optimizing reproductive outcomes and guiding appropriate management strategies.
Management of Postoperative Pain: Best Practices for GP’s
Effective management of postoperative pain is crucial for promoting recovery and preventing complications. General practitioners should start by assessing pain severity using appropriate scales, then tailor the treatment plan based on the patient's medical history and the type of surgery. A combination of pharmacological approaches, such as non-opioid analgesics (e.g., NSAIDs) and opioids when necessary, should be used to minimize pain while reducing the risk of addiction. Multimodal strategies, including physical therapy and non-pharmacological techniques like cold therapy or mindfulness, can further enhance pain relief. Close follow-up is essential to adjust the treatment as needed and ensure the patient's pain is well-controlled.
Diabetes and Stem Cells: What Does the Future Hold?
The future of diabetes treatment may be revolutionized by stem cell research, offering hope for a long-term cure. Scientists are developing stem cell therapies that could regenerate insulin-producing beta cells in the pancreas, potentially restoring natural insulin production in people with type 1 diabetes. Early clinical trials have shown promising results, with some patients reducing or eliminating their need for insulin injections. While challenges like immune rejection and long-term efficacy remain, continued advancements suggest stem cell therapy could significantly change diabetes management in the coming years.
Author Post